Gedeon Richter: A new hope for treatment-resistant schizophrenia?

Contributed by: PR Newswire

Tags

Gedeon-Richter-TRS

More Like This

Gedeon Richter: an effective treatment for female schizophrenia patients

Gedeon Richter: Cariprazine shows effectiveness in the treatment for dual disorder

Gedeon Richter: Cariprazine has a real chance of becoming the best-selling atypical antipsychotic drug

Gedeon Richter presents analysis on cannabis usage among patients with schizophrenia: a new medical solution to a severe issue might be available

PR Newswire associated0

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

PR Newswire associated0

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

PR Newswire associated0

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society